In patients with HCC, downregulated RFX1 is correlated with poor prognosis and high recurrence risk, whereas RFX1 overexpression decreases cancer invasion and epithelial-mesenchymal transition 55, which plays a crucial role in the early stages of metastasis 56,57. Here, RFX1 is linked to hepatocellular carcinoma.